PharmaCann and Cresco aggressively lobby in New York as state regulators mull adult-use expansion policy
Two Illinois companies – Oak Park-based PharmaCann and Chicago-based Cresco Labs – are investing in lobbyists.
Two Illinois companies – Oak Park-based PharmaCann and Chicago-based Cresco Labs – are investing in lobbyists.
Cannabis retailers are learning how to serve more customers amidst a cash-strapped industry and global economic crisis.
Conference organizers are reimagining what they do outside of the confines of a hotel or a convention hall.
The big Illinois news is that over the weekend Gov. J.B. Pritzker extended application deadlines for craft grower, cannabis infuser, and transporter licenses to April 30.
The State of Illinois has acknowledged our new essentials by allowing dispensaries to remain open while also allowing cultivators to use industrial hemp as an ingredient in THC-infused products.
Jennifer Taylor of Opt Out Naperville is calling for a do-over referendum in November.
Anecdotally, the cannabis industry seems to be doing O.K. But all reports are anecdotal at this point, since the state is late to update it’s monthly medical sales data.
“Everyone is losing money,” explains Kris Inton, an equity analyst who covers the cannabis sector for Chicago-based Morningstar.
Desperate times are calling for measures that only a few weeks ago would have seemed unheard of in the cannabis industry.
California and Colorado have a few years of legal recreational sales under their belts compared to Michigan and Illinois, which only have a few months, so it’s just a matter of time until Michigan and Illinois have sales proportionate to their populations vis-a-vis California and Colorado.